TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 91 filers reported holding TG THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $683,000 | -40.7% | 146,838 | -1.4% | 0.00% | 0.0% |
Q3 2016 | $1,152,000 | +27.6% | 148,863 | -0.2% | 0.00% | 0.0% |
Q2 2016 | $903,000 | -24.8% | 149,087 | +5.7% | 0.00% | -50.0% |
Q1 2016 | $1,201,000 | -18.7% | 140,985 | +13.8% | 0.00% | 0.0% |
Q4 2015 | $1,478,000 | +18.3% | 123,895 | +0.0% | 0.00% | 0.0% |
Q3 2015 | $1,249,000 | -40.0% | 123,886 | -1.2% | 0.00% | -33.3% |
Q2 2015 | $2,081,000 | +60.0% | 125,443 | +49.2% | 0.00% | +50.0% |
Q1 2015 | $1,301,000 | +5.3% | 84,061 | +7.7% | 0.00% | 0.0% |
Q4 2014 | $1,236,000 | +68.9% | 78,034 | +13.7% | 0.00% | +100.0% |
Q3 2014 | $732,000 | +15.1% | 68,610 | +1.3% | 0.00% | 0.0% |
Q2 2014 | $636,000 | +87.6% | 67,740 | +37.9% | 0.00% | – |
Q1 2014 | $339,000 | +105.5% | 49,105 | +16.0% | 0.00% | – |
Q4 2013 | $165,000 | -22.5% | 42,330 | 0.0% | 0.00% | – |
Q3 2013 | $213,000 | +10.4% | 42,330 | +40.4% | 0.00% | – |
Q2 2013 | $193,000 | – | 30,148 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |